The Journal of Bone and Joint Surgery (American). 2005;87:1965-1971.
doi:10.2106/JBJS.D.02440
© 2005 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the activities for this article:
 CME 3: July, August, September 2005
Adult Hip Reconstruction Test 16: Fall 2005
Right arrow [Supplementary Material]
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrett, J.
Right arrow Articles by Katz, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrett, J.
Right arrow Articles by Katz, J. N.
Related Collections
Right arrow Adult Hip
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?

Survival Following Total Hip Replacement

Jane Barrett, MSc1, Elena Losina, PhD2, John A. Baron, MD, MSc1, Nizar N. Mahomed, MD, ScD3, John Wright, MD4 and Jeffrey N. Katz, MD, MS4

1 Departments of Medicine (J.A.B.) and Community and Family Medicine (J.B. and J.A.B.), and Section of Biostatistics and Epidemiology (J.B. and J.A.B.), Dartmouth Medical School, Evergreen Building, Suite 300, 46 Centerra Parkway, Lebanon, NH 03766. E-mail address for J. Barrett: jane.a.barrett{at}dartmouth.edu
2 Department of Biostatistics, Boston University School of Public Health, 715 Albany Street, TE421, Boston, MA 02118
3 Musculoskeletal Health and Arthritis Program, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada
4 Section of Clinical Sciences, Division of Rheumatology, Immunology and Allergy (J.N.K.) and Department of Orthopaedic Surgery (J.W. and J.N.K.), Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115

Investigation performed at Dartmouth Medical School, Lebanon, New Hampshire, and Brigham and Women's Hospital, Boston, Massachusetts

In support of their research or preparation of this manuscript, one or more of the authors received grants or outside funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and from the Arthritis Foundation. None of the authors received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Background: Several studies have shown that patients who undergo total hip replacement live longer than control subjects, but the reason for this apparent protective effect is not clear. The purpose of our investigation was to assess whether the association had the characteristics of a causal relationship or whether it might appear to be due to comorbidity or other factors.

Methods: We compared survival over a six-year period for 28,469 Medicare enrollees who had elective primary total hip replacement in 1996 and a control group from the general Medicare population, matched 5:1 on year of birth, sex, race, and whether the Medicaid program paid the Medicare premium (a proxy for low income). For both the patients treated with total hip replacement and the control subjects, we used Medicare hospital claims to ascertain comorbidity, that is, whether the patient had had any of sixteen serious discharge diagnoses in the year prior to the total hip replacement (or an equivalent date for the controls). The survival patterns for the total hip arthroplasty and control cohorts were compared with use of proportional hazards regression for three follow-up periods: the first ninety days after surgery (or an equivalent date for the controls), ninety days to five years after surgery, and more than five years after surgery.

Results: The total hip replacement cohort had less comorbidity than the controls, with an approximately 30% lower prevalence for most serious diseases. Sex, age, Medicaid eligibility, and earlier serious comorbid diagnoses were important predictors of survival, but, even in analyses that adjusted for these variables, the total hip replacement cohort had better long-term survival than the controls. The patients who had a total hip replacement had a higher rate of mortality than the controls immediately after surgery, but, by three months postoperatively, the mortality rate for the patients was well below that for the controls. The overall rate of survival during the first ninety days was comparable for the two groups. From three months to five years after surgery, the mortality rate for the patients who had a total hip replacement was only two-thirds of that for the controls. After five years, the mortality rates for the two groups appeared to be converging.

Conclusions: Total hip replacement recipients survive longer than do matched controls in the Medicare population. The very rapid emergence of the lower mortality rate suggests that it is due to the selection of low-risk patients for elective surgery. However, our admittedly crude adjustment for comorbidity did not diminish the protective effect, so some effect of the procedure itself cannot be ruled out.

Level of Evidence: Therapeutic Level III. See Instructions to Authors for a complete description of levels of evidence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
J. A. Singh and J. A. Sloan
Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty
Rheumatology, December 1, 2008; 47(12): 1826 - 1831.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
E. Lau, K. Ong, S. Kurtz, J. Schmier, and A. Edidin
Mortality Following the Diagnosis of a Vertebral Compression Fracture in the Medicare Population
J. Bone Joint Surg. Am., July 1, 2008; 90(7): 1479 - 1486.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
S. M. Kurtz, K. L. Ong, J. Schmier, F. Mowat, K. Saleh, E. Dybvik, J. Karrholm, G. Garellick, L. I. Havelin, O. Furnes, et al.
Future Clinical and Economic Impact of Revision Total Hip and Knee Arthroplasty
J. Bone Joint Surg. Am., October 1, 2007; 89(suppl_3): 144 - 151.
[Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
N. Agabiti, S. Picciotto, G. Cesaroni, L. Bisanti, F. Forastiere, R. Onorati, B. Pacelli, P. Pandolfi, A. Russo, T. Spadea, et al.
The influence of socioeconomic status on utilization and outcomes of elective total hip replacement: a multicity population-based longitudinal study
Int. J. Qual. Health Care, February 1, 2007; 19(1): 37 - 44.
[Abstract] [Full Text] [PDF]